SDH缺陷癌症:分子机制和治疗策略
Jiaer Wang1,2, Tao Yuan1, Bo Yang1,3
1Engineering Research Center of Innovative Anticancer Drugs, Ministry of Education, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Hangzhou, China.
Cell biology and toxicology
|April 26, 2025
概括
癌症中酸脱酶 (SDH) 缺乏会破坏能量生产,并通过酸积累促进瘤生长. 了解这些机制有助于开发有针对性的癌症疗法.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 细胞生理学 细胞生理学
背景情况:
- 糖酸脱酶 (SDH) 连接TCA循环和电子运输链,这对ATP生产至关重要.
- 在各种癌症中观察到SDH缺乏,导致活性降低和酸盐积累.
- 累积的酸盐作为一种代谢物,驱动瘤的进展.
研究的目的:
- 审查SDH缺陷类型和瘤中的病理特征.
- 讨论SDH在致癌过程中的作用,将机制分类为依赖于酸盐或独立.
- 总结当前和临床前的SDH缺乏瘤管理策略.
主要方法:
- 关于癌症中SDH缺乏的文献综述.
- 分析SDH在瘤进展中的作用.
- 临床和临床前治疗策略的总结.
主要成果:
- SDH 缺乏症表现在具有特定病理特征的多种瘤类型中.
- 缺陷的SDH通过酸盐依赖和独立的途径促进癌症发生.
- 酸盐的积累是SDH缺乏癌症的标志,如GIST和色细胞瘤.
结论:
- SDH缺乏是特定癌症的关键驱动因素,涉及酸盐的积累.
- 准SDH或缩途径提供了潜在的治疗途径.
- 对SDH缺乏瘤管理的进一步研究是有必要的,以改善癌症治疗方法.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Cancer Stem Cells and Tumor Maintenance
4.6K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.6K


